Site‐Specific Mutations on KRAS, NRAS, and BRAF Corelate With the Frequency of ctDNA in Colorectal Cancer
ABSTRACT Background Early prediction of metastatic risk after tumor resection for colorectal cancer (CRC) is critical to improve treatment outcomes. Although circulating tumor DNA (ctDNA) is an important biomarker in CRC patients, positivity is variable because cutoff values for each gene have not b...
Saved in:
Main Authors: | Fumihiro Yoshimura, Yoichiro Yoshida, Teppei Yamada, Keita Tanaka, Takaomi Hayashi, Hideki Shimaoka, Ryohei Sakamoto, Naoya Aisu, Gumpei Yoshimatsu, Suguru Hasegawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-07-01
|
Series: | Cancer Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/cnr2.70292 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
INFLUENCE OF SOMATIC MUTATIONS OF KRAS, NRAS, BRAF AND MICROSATELLITE INSTABILITY STATUS ON SURVIVAL OF COLORECTAL CANCER PATIENTS WITH PERITONAL CARCINO
by: V. P. Shubin, et al.
Published: (2020-10-01) -
The role of KRAS and NRAS mutation detection in determining the therapy strategy for colorectal cancer
by: A. N. Toropovskiy, et al.
Published: (2022-11-01) -
The combination of mutations in BRAF and NRAS genes within a one tumor in patients with cutaneous melanoma
by: M. B. Aksenenko, et al.
Published: (2019-10-01) -
Mutaciones de KIT, NRAS y BRAF en melanoma
by: Luz de María Díaz-Granados, et al.
Published: (2019-08-01) -
Eosinophilic Cells as a Distinct Morphological Feature in <i>BRAF<sup>V600E</sup></i>-Mutated Ovarian Serous Borderline Tumors
by: Alina Badlaeva, et al.
Published: (2025-06-01)